Relationship of bone mineral density with disease activity and functional ability in patients with ankylosing spondylitis: A cross-sectional study

Rheumatology International

Volumn 32, Issue 9, 2012, Pages 2801-2808

  Grazio, Simeon ^a   Kusić, Zvonko ^a   Cvijetić, Selma ^b   Grubišić, Frane ^a   Balenović, Antonija ^c   Nemčić, Tomislav ^a   Matijević Mikelić, Valentina ^a   Punda, Marija ^a   Sieper, Joachim ^d  

^a SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

^b INSTITUTE FOR MEDICAL RESEARCH AND OCCUPATIONAL HEALTH   (Croatia)

^c Department of Radiology   (Croatia)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Ankylosing spondylitis; Bone mineral density; Disease activity; Functional ability

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; BONE DENSITY; CROSS-SECTIONAL STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FEMUR; HEALTH STATUS; HIP; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; OSTEOPENIA; OSTEOPOROSIS; PRIORITY JOURNAL; SCORING SYSTEM; SPINAL PAIN; VISUAL ANALOG SCALE;

EID: 84866372235     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-011-2066-9     Document Type: Article

References (38)

1. Thomas GP, Brown MA (2010) Genetics and genomics of ankylosing spondylitis. Immunol Rev 233:162-180
2. Cooper C, Carbone L, Michet CJ, Atkinson EJ, O'Falon WM, Melton J (1994) Fracture risk in patients with ankylosing spondylitis: a population based study. J Rheumatol 21:1877-1882 (Pubitemid 24312651)
3. Hunter T, Dubo HIC (1983) Spinal fractures complicating ankylosing spondylitis: a long-term follow-up study. Arthritis Rheum 26:751-759 (Pubitemid 13099994)
4. Ralston SH, Urquhart GDK, Brzeski M, Sturrock RD (1990) Prevalence of vertebral compression fractures due to osteoporosis in ankylosing spondylitis. BMJ 300:563-565 (Pubitemid 20090269)
5. Baek HJ, Kang SW, Lee YJ et al (2005) Osteopenia in men with mild and severe ankylosing spondylitis. Rheumatol Int 26:30-34 (Pubitemid 41531511)
6. World Medical Organization (1996) Declaration of Helsinki. Brit Med J 313(7070):1448-1449
7. Calin A, Garrett S, Whitelock H et al (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the bath ankylosing spondylitis functional index. J Rheumatol 21:2281-2285
8. Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the bath ankylosing spondylitis disease activity index. J Rheumatol 21:2286-2291
9. Grazio S, Grubisić F, Nemcić T, Matijević V, Skala H (2009) The reliability and validity of a Croatian version of the bath ankylosing spondylitis functional index and bath ankylosing spondylitis disease activity index in patients with ankylosing spondylitis. Reumatizam 56:63-76 (article in Croatian)
10. Kanis JA, Johnell O, Oden A, Jonsson B, De Laet C, Dawson A (2000) Risk of hip fracture according to world health organization criteria for osteoporosis and osteopenia. Bone 27:585-590
11. Kanis JA, Johnell O, Oden A, Johansson H, McCloskey E (2008) FRAXTM, the assessment of fracture probability in men, women from the UK. Osteoporos Int 19:385-397
12. WHO (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser 843:1-129
13. Siris ES, Chen YT, Abbott TA et al (2004) Bone mineral density thresholds for pharmacological intervention to prevent fractures. Arch Intern Med 164:1108-1112 (Pubitemid 38668990)
14. McDonald BR, Gowen M (1992) Cytokines and bone. Br J Rheumatol 31:149-155
15. Briot K, Gossec L, Kolta S, Dougados M, Roux C (2008) Prospective assessment of body weight, body composition, and bone density changes in patients with spondyloarthropathy receiving anti-tumour necrosis factor-alpha treatment. J Rheumatol 35:855-861 (Pubitemid 351747128)
16. Barnabe C, Hanley DA (2009) Effect of tumour necrosis factor alpha inhibition on bone density and turnover markers in patients with rheumatoid arthritis and spondyloarthropathy. Semin Arthritis Rheum 39:116-122
17. Visvanathan S, van der Heijde D, Deodhar A et al (2009) Effects of infliximab on markers of inflammation and bone turnover and associations with bone mineral density in patients with ankylosing spondylitis. Ann Rheum Dis 68:175-182
18. Allali F, Breban M, Porcher R, Maillefert JF, Dougados M, Roux C (2003) Increase in bone mineral density of patients with spondyloarthropathy treated with anti-tumour necrosis factor alpha. Ann Rheum Dis 62:347-349 (Pubitemid 36363442)
19. Laan R, Buijs W, Draad M et al (1991) Bone mineral density in rheumatoid arthritis: influence of disease activity and functional capacity. Arthritis Rheum 34:S180
20. Yildirim K, Karatay S, Cetinkaya R et al (2009) Bone mineral density in patients with familial Mediterranean fever. Rheumatol Int 30:305-308
21. Sieper J (2009) Can structural damage be prevented in ankylosing spondylitis? Curr Opin Rheumatol 21:335-339
22. Başkan BM, Dogan YP, Sivas F, Bodur H, Ö zoran K (2010) The relation between osteoporosis and vitamin D levels and disease activity in ankylosing spondylitis. Rheumatol Int 30:375-381
23. Ghozlani I, Ghazi M, Nouijai A et al (2009) Prevalence and risk factors of osteoporosis and vertebral fractures in patients with ankylosing spondylitis. Bone 44:772-776
24. Gratacos J, Collado A, Pons F et al (1999) Significant loss of bone mass in patients with early, active ankylosing spondylitis: a follow-up study. Arthritis Rheum 42:2319-2324 (Pubitemid 30333411)
25. Incel NA, Gokoglu F, Nacir B, Incel N (2006) Bone and stone in ankylosing spondylitis: osteoporosis and urolithiasis. Clin Rheumatol 25:667-670 (Pubitemid 44111308)
26. Lange U, Teichmann J, Strunk J, Müller-Ladner U, Schmidt KL (2005) Association of 1.25 vitamin D3 deficiency, disease activity and low bone mass in ankylosing spondylitis. Osteoporos Int 16:1999-2004 (Pubitemid 41790919)
27. Toussirot E, Michel F, Wendling D (2001) Bone density, ultrasound measurements and body composition in early ankylosing spondylitis. Rheumatology 40:882-888
28. Ozgocmen S, Godekmerdan A, Ozkurt-Zengin F (2007) Acutephase response, clinical measures and disease activity in ankylosing spondylitis. Jt Bone Spine 74:249-253 (Pubitemid 46720043)
29. Przepiera-Bedzak H (2007) The value of researches, which assess bone mineral density and bone metabolism in patients with ankylosing spondylitis, in detecting osteoporosis. Ann Academ Med Stetinen 53:39-47 (article in polish)
30. Karberg K, Zochling J, Sieper J, Felsenberg D, Braun J (2005) Bone loss is detected more frequently in patients with ankylosing spondylitis with syndesmophytes. J Rheumatol 32:1290-1298 (Pubitemid 40995385)
31. Toussirot E, Wendling D (2000) Bone mass in ankylosing spondylitis. Clin Exp Rheumatol 18(Suppl 21):S16-S20
32. Borman P (2004) Functional disability and quality of life in patients with ankylosing spondylitis. Rheumatol Int 24:59-60 (Pubitemid 38168119)
33. El Maghraoui A (2004) Osteoporosis and ankylosing spondylitis. Jt Bone Spine 71:291-295 (Pubitemid 39037316)
34. Capaci K, Hepguler S, Argin M, Tas I (2003) Bone mineral density in mild and advanced ankylosing spondylitis. Yonsei Med J 44(3):379-384 (Pubitemid 36833888)
35. Mitra D, Elvins DM, Speden DJ, Collins AJ (2000) The prevalence of vertebral fractures in mild ankylosing spondylitis and their relationship to bone mineral density. Rheumatology 39:85-89 (Pubitemid 30095412)
36. Grubisić F, Grazio S, Balenović A, Nemcić T, Kusić Z (2009) Osteoporosis, spinal mobility and chest expansion index in patients with ankylosing spondylitis. Coll Antrop (accepted for publication)
37. Sarikaya S, Basaran A, Tekin Y, Ozdolap S, Ortancil O (2007) Is osteoporosis generalized or localized to central skeleton in ankylosing spondylitis? J Clin Rheumatol 13:20-24 (Pubitemid 46213838)
38. Lange U, Jung O, Teichmann J, Neeck G (2001) Relationship between disease activity and serum levels of vitamin D metabolites and parathyroid hormone in ankylosing spondylitis. Osteoporos Int 12:1031-1035 (Pubitemid 34105974)